Home›Stock Screener›Innova Captab

Innova Captab Share Price Today | Stock Price & Innova Captab Share Screener

INNOVACAP Pharmaceuticals
Live Share Price NSE
₹1145.40
▼ -22.60 (-1.93%)
2026-10-05 00:00:00
Live Share Price BSE
₹1145.15
▼ -22.45 (-1.92%)
2026-10-05 00:00:00

As of October 5, 2026, the live Innova Captab share price (NSE: INNOVACAP) is ₹1,145.40 on NSE and ₹1,145.15 on BSE, down 1.93% from the previous close, with shares trading between ₹1,119.80 and ₹1,193.00 in today's trading session, and a 52-week range of ₹644.75–₹1,297.60. Check INNOVACAP annual price range for the annual price range and momentum. Use the Innova Captab stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Innova Captab opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹473 and net income of ₹44, with EBITDA of ₹75, an operating margin of 16.0% and a profit margin of 9.3%.

Innova Captab Market Cap ₹7,274.43 Cr.
INNOVACAP P/E Ratio (TTM) 47.23
Innova Captab P/B Ratio 6.67
EPS (TTM) ₹24.63
Dividend Yield 0.16%
Debt to Equity 0.33
INNOVACAP 52 Week High ₹1297.60
Innova Captab 52 Week Low ₹644.75
Operating Margin 16.00%
Profit Margin 9.30%
INNOVACAP Revenue (TTM) ₹473.00
EBITDA ₹75.00
Net Income ₹44.00
Total Assets ₹1,837.00
Total Equity ₹1,091.00

Innova Captab Share Price Chart

Track the current stock price of Innova Captab with an interactive chart. Analyse INNOVACAP share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Innova Captab stock quote in one place.

The quote of ₹1,145.40 sits between the 52-week low of ₹644.75 and the 52-week high of ₹1,297.60, and the latest session moved -1.93% from the previous close.

Innova Captab Company Profile - Fundamental Screener

Screen Innova Captab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INNOVACAP shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0DUT01020.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE0DUT01020

Innova Captab Balance Sheet Screener

Screen INNOVACAP balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹1,837, up from ₹1,580 in 2025.

Latest statistics put total assets at ₹1,837 and shareholder funds at ₹1,091, with a leverage ratio of 0.33.

Item 2026 2025 2024 2023 2022 2021 2020 2019

Assets

Total Assets 1,837 1,580 1,321 704 576 370 245 0
Current Assets 923 696 580 443 379 271 171 0
Fixed Assets 842 830 358 183 183 79 73 0

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 252 268 225 150 72 10 14 0
Non-Current Liabilities 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 1,091 959 831 277 209 145 110 0
Share Capital 57 57 57 48 12 12 12 0
Reserves & Surplus 1,034 902 774 229 197 133 98 0

Innova Captab Income Statement Screener - Profit & Revenue Analysis

Screen Innova Captab income statement and profit fundamentals. Analyze INNOVACAP quarterly results. Innova Captab reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹473 and net profit was ₹44, equal to earnings per unit of ₹7.71, at an operating margin of 16%.

In that period expenses were ₹398, interest cost ₹4 and tax ₹15. The next period listed, 2026-Mar, shows revenue of ₹449 and net profit of ₹38.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec

Revenue and Expenses

Revenue 473 449 452 385 356 318 321 320 296 268 305 286 234 244 245
Expenses 398 383 381 329 299 267 270 269 252 225 258 243 202 214 208

Operating Costs and Margins

EBITDA 75 67 71 56 57 51 51 52 44 44 47 44 32 29 37
Operating Profit % 16.00% 15.00% 15.00% 14.00% 15.00% 15.00% 15.00% 16.00% 14.00% 15.00% 15.00% 14.00% 13.00% 11.00% 14.00%
Depreciation 12 11 11 11 11 10 5 5 5 3 5 5 3 3 3
Interest 4 5 4 6 3 2 0 0 0 1 7 9 5 5 6

Profit and Earnings

Profit Before Tax 59 51 56 39 43 39 46 47 39 40 35 30 25 21 28
Tax 15 13 14 10 12 10 11 12 10 11 10 7 7 4 9
Net Profit 44 38 42 30 31 30 34 35 30 29 25 23 18 17 20
EPS 7.71 6.65 7.37 5.18 5.42 5.17 5.97 6.12 5.15 5.02 4.39 4.77 3.67 3.59 4.08

Innova Captab Cash Flow Screener - Liquidity Fundamentals

Screen INNOVACAP cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹117, and net cash flow was an outflow of ₹12.

Over the same period, investing activities used ₹107 and financing activities used ₹22.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March

Cash from Operations and Investing

Operating Activities 117 64 146 67 59 42 31 19
Investing Activities -107 -152 -499 -91 -188 -20 -6 -9

Financing and Net Cash

Financing Activities -22 92 361 27 125 -19 -23 -9
Net Cash Flow -12 4 8 3 -5 3 2 1

Innova Captab Shareholding Pattern Screener

See Innova Captab shareholding pattern with promoter, FII, and DII holdings. Check Innova Captab promoter holding and ownership changes for INNOVACAP on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 50.90%, foreign institutions 0.23%, domestic institutions 20.14% and the public 27.11%, spread across 36,965 shareholders.

The shareholder count was 36,965 in 2026-Mar, compared with 35,881 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 50.90% 50.90% 50.90% 50.90% 50.90% 50.90% 50.90% 50.90%

Institutional Investors

FII Holding 0.23% 0.34% 0.34% 0.23% 0.08% 0.11% 1.94% 1.19%
DII Holding 20.14% 19.92% 19.76% 19.67% 20.17% 20.24% 20.77% 21.23%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 27.11% 27.22% 27.62% 27.71% 27.35% 27.22% 25.47% 25.80%
Other Holding 1.62% 1.62% 1.37% 1.49% 1.50% 1.53% 0.91% 0.88%
Shareholder Count 36,965 35,881 39,996 41,014 40,245 38,691 39,396 35,115

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Innova Captab. Innova Captab dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹2.00 per unit for 2026-March, a yield of 0.16%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹2.00, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹2.00 0.16%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Innova Captab Stock Index Membership - Nifty & Sensex

See which indices include Innova Captab stock. Check INNOVACAP index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 6 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP, NIFTY IPO.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY IPO
NIFTY MICROCAP250
NIFTY TOTAL MKT

Innova Captab Market Events Screener - Corporate Actions

Get Innova Captab corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Innova Captab stock events that may affect INNOVACAP share price, along with derivatives, futures and options activity and sector gainers.

14 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.

It is followed by Quarterly Result Announcement dated August 21, 2026 and Quarterly Result Announcement dated August 11, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-30 2026-09-30 Annual General Meeting NA 12.96%
2026-08-21 2026-08-21 Quarterly Result Announcement NA 4.55%
2026-08-11 2026-08-11 Quarterly Result Announcement NA 2.38%
2026-06-29 2026-06-29 Annual General Meeting NA 9.56%
2026-05-07 2026-05-07 Quarterly Result Announcement NA 20.86%
2026-01-30 2026-01-30 Dividend ₹ 2.00 /share 3.53%
2026-01-23 2026-01-23 Quarterly Result Announcement NA -3.70%
2025-11-07 2025-11-07 Quarterly Result Announcement NA -1.75%
2025-08-07 2025-08-07 Quarterly Result Announcement NA 3.01%
2025-07-31 2025-07-31 Annual General Meeting NA 8.82%
2025-05-19 2025-05-19 Quarterly Result Announcement NA 9.28%
2025-02-05 2025-02-05 Quarterly Result Announcement NA 12.54%
2024-11-07 2024-11-07 Quarterly Result Announcement NA 13.66%
2024-09-18 2024-09-18 Annual General Meeting NA 16.12%

Innova Captab Competitors Screener - Peer Stocks Comparison

Screen INNOVACAP competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 447,476 36.44 61,674 12.69% 11,565 47.42
Divis Laboratories 250,363 86.51 11,067 13.95% 2,568 58.71
Torrent Pharmaceuticals 186,152 85.91 13,886 20.34% 2,138 48.14
Zydus Life Science 120,798 26.32 27,658 17.64% 5,026 61.81
Cipla 111,426 33.44 29,045 2.24% 3,870 44.03
Laurus Labs 106,838 99.70 6,868 22.01% 890 58.00
Mankind Pharma 105,107 48.73 14,636 14.85% 1,938 64.24
Dr Reddys Laboratories 104,492 32.05 35,059 3.90% 4,158 69.59
Aurobindo Pharma 97,682 26.36 34,145 5.56% 3,503 54.69
Lupin 93,829 16.99 29,039 26.75% 5,356 34.02

Innova Captab Company Announcements - News & Reports Screener

Screen INNOVACAP latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 5, 2026.

The next most recent announcements are dated September 15, 2026 and September 5, 2026.

Date Update Actions
2026-10-05 Closure of Trading Window -
2026-09-15 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-05 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-05 Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-09-04 Business Responsibility and Sustainability Reporting (BRSR) -
2026-09-04 Reg. 34 (1) Annual Report. -
2026-09-04 Notice Convening The 22Nd Annual General Meeting (AGM) And Submission Of Integrated Annual Report Of The Company For The Financial Year 2025-2026. -
2026-09-03 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-03 Board Meeting Outcome for Outcome Of The Board Meeting -
2026-08-23 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-22 Approval Of AGM Notice -
2026-08-22 In Terms Of Regulations 30 Of The Listing Regulations The Board Of Directors Of The Company Had Approved A Brownfield Expansion -
2026-08-22 Outcome Of The Board Meeting Dated I.E. 21St August 2026 -
2026-08-22 Board Meeting Outcome for Outcome Of The Board Meeting Dated I.E. 21St August 2026 -
2026-08-18 Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-08-14 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-08-13 Closure of Trading Window -
2026-08-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-08-12 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-11 Approval Of The Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June 2026. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹1,145.40, within a 52-week range of ₹644.75 to ₹1,297.60. The P/E ratio is 47.23 and the P/B ratio is 6.67, with earnings per unit of ₹24.63. Market capitalisation stands at ₹7,274.43 Cr and the dividend yield is 0.16%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 8 balance sheet periods, 15 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.